Partner with us
Studies
/
Effect of exogenous β-hydroxybutyrate on BDNF signaling, cognition, and amyloid precursor protein processing in humans with T2D and insulin-resistant rodents
Ketone ester/other
Human RCT
2025

Effect of exogenous β-hydroxybutyrate on BDNF signaling, cognition, and amyloid precursor protein processing in humans with T2D and insulin-resistant rodents

Key finding
Ketone supplementation did not raise BDNF content in humans with type 2 diabetes or in mice, although it positively modulated BACE1 activity in the mice.
What the study did

This paper reports parallel human and rodent studies of exogenous ketone supplementation, with the human arm testing acute and short-term ketone monoester supplementation in adults with type 2 diabetes and the rodent arm testing acute and chronic beta-hydroxybutyrate in C57BL/6J mice with and without insulin resistance. The outcomes were circulating or cortical BDNF, cognition or recognition memory, and amyloid precursor protein processing. Ketone supplementation did not change plasma BDNF or cognition in humans, and did not change recognition memory or cortical BDNF in mice.

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB